ELVN
Enliven TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
RSI (14)
47.0
Neutral
MACD Hist
-0.47
Bearish
ATR (14)
2.00
Normal
Vol Z (20)
1.60
Normal
RET 20D
-0.8%
Negative
Dist 52W High
-6.1%
Below High
Technical chart
1 YearCandles, moving averages, and volume using the current RankAlpha theme.
As of 2026-09-09
Price
SMA 20
SMA 50
SMA 200
Trend readout
Technical readout
Trend
Uptrend (SMA20 > SMA50 > SMA200)
Momentum
Short-term pullback vs positive 3M trend · 20D -0.8% · 60D +35.6%
RSI / MACD
RSI 47.0 (Neutral) · MACD hist -0.47
Volatility
Volatility elevated (Z 1.60)
SMA20
59.22
SMA50
55.98
SMA200
37.99
EMA12
58.92
EMA26
58.18
BB Upper
61.44
BB Mid
59.22
BB Lower
57.00
RET 5D
-2.6%
RET 20D
-0.8%
RET 60D
+35.6%
RET 120D
+91.2%
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data

